The partnership brings data-driven men’s healt
Author: Michael
Biogen and Ionis report first Phase 2 evidence t
Harvard Health Publishing’s first longevity re
Scribe Therapeutics has secured clearance from Au
Alzinova is preparing for a global phase II study
MBX Biosciences, Inc.
Biotech firms, including Regenxbio, Novartis and
The Korean Society of Hypertension has incorporat
Korean pharma company targets regenerative medic
Milan panel explores how longevity medicine is s